Is Vontier Corporation VNT stock worth adding exposure to Q4 2025 EPS Beats Forecasts Is Destra Multi DMA stock a logical buy right now Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus CXAI CXApp shares edge higher even as its Q4 2025 earnings narrowly miss consensus analyst estimates GATX Corporation GATX Stock Market Update Steady Decline 20260427